摘要
对东莨菪素的3位进行结构修饰,通过引入不同取代的苯甲酰胺基团,设计并合成了9个未见文献报道的新化合物(10a^10i),其结构经ESI-MS、IR和1H NMR确认。采用MTT法评价了化合物对MCF-7、A549及HCT-116肿瘤细胞的抗增殖作用。结果表明,部分化合物对肿瘤细胞具有较好抗增殖作用,其中化合物10g抗增殖活性最强,强于阳性对照药东莨菪素和舒尼替尼。
To explore novel seopoletin derivatives with more potent antiproliferative activity, a series of com- pounds were designed and synthesized (10a-10i) by linking benzamide to seopoletin's framework. Their structures were determined by ESI-MS, IR and I H NMR. The antiproliferative activity of the synthetic derivatives against human cancer cells MCF-7, A549 and HCT-116 was evaluated by MTT assay. Preliminary experimental results showed that compound 10g was the most potent one, whose antiproliferative activity was stronger than that of the positive control seopoletin and sunitinib.
出处
《中国药科大学学报》
CAS
CSCD
北大核心
2015年第2期169-173,共5页
Journal of China Pharmaceutical University
基金
中国药科大学华海药业研究生创新基金项目(No.CX13S-006HH)~~
关键词
东莨菪素
衍生物
合成
抗增殖活性
seopoletin
derivative
synthesis
antiproliferative activity